Institute of Microbial Technology (IMTECH), Chandigarh, is a premier research institute under the Council of Scientific & Industrial Research (CSIR), Government of India, dedicated to cutting-edge research in microbial biotechnology, genomics, and biomedical applications.
Explore Research Contact UsResearch Labs
Scientists & Staff
Publications
Patents Granted
Established in 1984, the Institute of Microbial Technology (IMTECH) has emerged as a national leader in microbial research and biotechnology. Located in the beautiful city of Chandigarh, India, our institute operates under the aegis of the Council of Scientific and Industrial Research (CSIR), Ministry of Science & Technology, Government of India.
Our mission is to conduct high-quality basic and applied research in microbial sciences, to generate knowledge and develop technologies for the benefit of society, industry, and the environment. We aim to understand microbial systems at molecular, cellular, and community levels, and harness their potential for healthcare, agriculture, energy, and environmental sustainability.
IMTECH houses state-of-the-art infrastructure, including advanced sequencing facilities, high-throughput screening platforms, fermentation pilot plants, and animal house facilities, enabling multidisciplinary research across various domains of microbiology and biotechnology.
Deciphering the genetic blueprint of microbes for novel applications in medicine and industry.
Identifying new antimicrobials, antifungals, and bioactive molecules from microbial sources.
Developing microbial solutions for waste treatment, bioremediation, and sustainable agriculture.
Our research is organized into interdisciplinary divisions that collaborate to address complex scientific challenges.
Focuses on whole-genome sequencing, comparative genomics, metagenomics, and functional genomics of bacteria, archaea, and fungi. Key projects include pathogen genome analysis, microbiome studies, and evolutionary genomics.
Engaged in structural and functional characterization of microbial proteins, enzymes, and complexes using X-ray crystallography, cryo-EM, NMR, and biophysical techniques. Aims to understand enzyme mechanisms and engineer novel biocatalysts.
Investigates host-pathogen interactions, immune responses, and develops novel diagnostics, vaccines, and therapeutics against bacterial, fungal, and viral pathogens of medical importance.
Focuses on upstream and downstream bioprocess development for the production of microbial metabolites, enzymes, antibiotics, and recombinant proteins using bioreactor systems and scale-up methodologies.
Explores microbial diversity in extreme environments, bioremediation of pollutants, waste-to-energy conversion, and plant-microbe interactions for sustainable agriculture.
Develops computational tools and databases for genomic, proteomic, and metabolomic data analysis, systems biology modeling, and in silico drug design.
IMTECH provides shared access to advanced technological platforms that support the research community both within and outside the institute.
Equipped with Illumina NovaSeq 6000, MiSeq, and Oxford Nanopore platforms for whole genome, transcriptome, and metagenome sequencing.
Houses 800 MHz NMR, single-crystal X-ray diffractometers, and cryo-electron microscope for protein structure determination.
Robotic liquid handlers and automated imaging systems for screening large compound libraries against microbial targets.
Includes 30L to 1000L fermenters with advanced control systems for process optimization and scale-up studies.
Cluster with 500+ cores, GPU nodes, and petabyte-scale storage for bioinformatics and computational biology research.
Confocal, super-resolution, and live-cell imaging systems for studying microbial cells and host-pathogen interactions.
March 15, 2024 | Nature Microbiology
IMTECH researchers have isolated a new polyene compound from a marine Streptomyces species that shows potent activity against drug-resistant Candida auris and Aspergillus fumigatus. The compound, named Imtechin A, targets fungal ergosterol biosynthesis with a novel mechanism.
February 28, 2024 | ISME Journal
Scientists at the Environmental Microbiology department have sequenced and annotated the genome of Geobacter sulfurreducens strain IMT-7, revealing unique genes for extracellular electron transfer, which could enhance microbial fuel cell efficiency.
January 10, 2024 | Cell Reports
The Protein Science department has determined the high-resolution structure of the Cas12a-guide RNA-target DNA ternary complex from a thermophilic bacterium, providing insights for improved genome editing tools.
December 5, 2023 | Journal of Clinical Microbiology
A lateral flow assay developed at IMTECH can detect NDM-1 and KPC carbapenemases directly from clinical samples within 30 minutes, with sensitivity and specificity over 95%. The technology has been licensed to a diagnostic company.
May 20-22, 2024
"Microbes in One Health" – Register now for keynote lectures, poster sessions, and workshops.
April 10, 2024
A startup incubator to support entrepreneurial scientists in translating microbial technologies to market.
March 28, 2024
Joint initiative to establish a national surveillance network for antibiotic-resistant pathogens.
March 1, 2024
Applications invited for the PhD program in Microbial Biotechnology. Deadline: April 30, 2024.
We work with leading academic, industrial, and governmental partners worldwide.
Sector 39-A, Chandigarh 160036, India
+91-172-6665 234
+91-172-6665 235
www.yankezs.com
Monday to Friday: 9:00 AM to 5:30 PM
Saturday: 9:00 AM to 1:00 PM
Closed on Sundays and Public Holidays
[email protected] | +91-172-6665 236
For licensing and collaboration opportunities:
[email protected] | +91-172-6665 237